CAH Cardinal Health, Inc. Common Stock
Про Cardinal Health, Inc. Common Stock Огляд компанії з Wikipedia
Cardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.
Детальніше
Cardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.
History
Founded in 1971 as Cardinal Foods by Robert D. Walter, the company was initially a food wholesaler. After acquiring the Bailey Drug Company in 1979, it began whole selling drugs. The company went public on the NASDAQ stock exchange in 1983.
In 1988, Walter sold Cardinal Health's food operations to Roundy's. From 1991 to 1996, the company's sales grew from $1.2 billion to $8.9 billion. The company changed its name to Cardinal Health in 1994, and became the third-largest pharmaceutical wholesaler in the United States.
2000–2019
R. Kerry Clark, a former executive and vice chairman at Procter & Gamble, was appointed president and CEO in April 2006, with Robert D. Walter retaining Chairmanship of the board. In September 2008, the company announced Clark and Walter would retire and George S. Barrett would become the chairman and CEO.
In 2009, Cardinal Health completed the spin-off of its clinical and medical products businesses into an independent medical technology company called CareFusion with David Schlotterbeck as CEO. Cardinal Health is now traded on the NYSE under symbol CAH.
In December 2013, it was announced that Cardinal Health would partner with CVS Caremark to form a generic drug sourcing operation in the United States. The venture was named Red Oak Sourcing and began operations in July 2014.
Between 2014 and 2016, Cardinal, alongside McKesson Corporation, and AmerisourceBergen, spent $13 million lobbying Congress to pass Congressman Tom Marino's "Ensuring Patient Access and Effective Drug Enforcement Act". The bill, which increases the burden of proof enforcers need to show against drug distributors, was signed into law by President Barack Obama in April 2016.
In January 2018, Michael Kaufmann assumed the role of CEO after serving as CFO of the company.
Opioid lawsuits
In 2019, Cardinal was one of several drug distributors named in lawsuits related to the opioid crisis in the US. In July 2021, Cardinal Health and other pharmaceutical companies agreed to participate in a $26 billion settlement. Cardinal will pay $6.4 billion over 18 years.
In May 2020, Oklahoma Attorney General Mike Hunter sued Cardinal Health in Bryan County District Court, Oklahoma. The lawsuit alleged that the company's actions helped fuel Oklahoma's opioid crisis. The suit was filed along with lawsuits against AmerisourceBergen and McKesson, and the three lawsuits allege that the three companies provided "enough opioids to Bryan County that every adult resident there could have had 144 hydrocodone tablets."
2020–present
As of August 2021, it is ranked 14 on the Fortune 500 list with FY2020 annual revenue of $152.9 billion. The firm employs 57,000 people worldwide.
Acquisitions
In 1995, Medicine Shoppe International, the country's largest franchiser of retail pharmacies, was acquired. The merger represented the first non-distribution acquisition by Cardinal Health.
In 1996, Cardinal Health acquired Pyxis Corporation, a company that developed automated pill dispensers for hospitals, for $867 million.
In 1997, Cardinal Health planned to purchase Bergen Brunswig Corp., to which McKesson Corporation responded with a bid to purchase Amerisource. Instead, Amerisource and Bergen merged into AmerisourceBergen. Later that year, Cardinal Health completed the acquisition of Owen Healthcare, the second-largest provider of pharmacy management services in the U.S. at the time.
In 1999, the firm acquired the Chicago-based medical products manufacturer and distributor, Allegiance Healthcare (formerly a division of Baxter Healthcare). In 2001, the company acquired Bindley Western Industries, a wholesale distributor of pharmaceuticals based in Indianapolis.
In April 2006, Cardinal Health purchased Niagara Falls-based ParMed Pharmaceuticals for $40.1 million. In June 2007, the firm announced the completion of a tender offer for VIASYS Healthcare.
In June 2010, Cardinal Health announced plans to purchase Healthcare Solutions Holding, a specialty pharmaceutical services company, for $517 million. In December 2010, the company acquired Kinray, an independent pharmaceutical wholesaler, increasing Cardinal Health's presence in the independent pharmacy market by 40 percent. From 2010 to 2014, Cardinal Health acquired 18 companies including Yong Yu, a Chinese drug distributor. Cardinal sold Yong Yu in 2017 to Shanghai Pharmaceuticals Holding Co. Ltd. for $1.2 billion.
On March 18, 2013, Cardinal Health acquired the Twinsburg, Ohio-based privately held medical supply distributor AssuraMed, and with it its subsidiaries including Edgepark Medical Supplies, for $2.7 billion. AssuraMed was backed by private equity firms Clayton, Dubilier & Rice and Goldman Sachs Alternatives.
In July 2014, Cardinal Health and CVS formed Red Oak Sourcing, the largest generic drug sourcing operation in the United States. The companies started buying generic drugs around the world to sell in U.S. markets.
In March 2015, Cardinal Health signed an agreement to acquire Johnson & Johnson's Cordis (medical) division, a cardiology and endovascular device manufacturer, for $1.94 billion. The acquisition was completed on October 4, 2015. Cardinal sold the division in August 2021 to Hellman & Friedman, a private equity firm, for $1 billion.
In April 2017, Cardinal Health announced the plan to acquire the patient product portfolio from Medtronic for $6.1 billion. The acquisition was completed on July 30, 2017.
In November 2024, Cardinal Health announced the plan to acquire Advanced Diabetes Supply Group (ADSG), a leading national direct-to-patient provider of diabetes medical supplies, for about $1.1 billion with plans to merge the company into its at-Home Solutions business. The at-Home Solutions business includes Edgepark Medical Supplies of Twinsburg, Ohio and United States Medical Supply (US MED) of Doral, Florida. The acquisition was complete by April 2024.
In August 2025, Cardinal Health announced that it would acquire a 75% stake in Solaris Health, the largest urology management services organization (MSO) in the United States, for $1.9 billion in cash.
In July 2026, Cardinal Health agreed to acquire AdaptHealth's diabetes health business and medical-supply provider Strive Medical in separate transactions worth approximately US$360 million in total. The acquisitions were intended to expand its at-Home Solutions business in diabetes and urological care.
Controversy
Role in the Opioid epidemic
Multiple legal settlements have demonstrated Cardinal Health's role in the US Opioid epidemic, though the company never admitted wrongdoing:
December 2016: Cardinal Health settled for $44 million for violations of the Controlled Substances Act brought in allegations from United States Attorneys in districts from Maryland, New York, Florida and Washington.
July 2021: Cardinal Health agreed to pay $6.4 billion to settle thousands of US lawsuits. They were one of four companies to pay $26 billion, including Johnson & Johnson, AmerisourceBergen and McKesson.
May 2022: Settled a derivative suit on behalf of shareholders for $124 million.
August 2024: Settlement with various health plans including insurers and third-party payers for $92.7 million.
August 2024: Settlement with the City of Baltimore for $152.5 million.
Restatements
In September 2004, Cardinal Health announced plans to restate past results for fiscal 2001, 2002, 2003, and the first three quarters of 2004 downward, after an accounting review and an ongoing federal investigation. In 2005, in connection with the Audit Committee's conclusions reached in September and October 2004, the company made certain reclassification and restatement adjustments to its fiscal 2004 and prior historical consolidated financial statements. According to The Wall Street Journal, "Analysts called the restatement decision troubling, yet limited in scope."
FDA action
In August 2006, Cardinal Health ceased production of its Alaris SE infusion pump after approximately 1300 units were seized by the United States Food and Drug Administration (FDA). In February 2007, Cardinal Health signed a consent decree with the FDA which promised procedures to guarantee the safety of the Alaris SE. After FDA inspections, Cardinal Health entered into a further consent agreement with the FDA in 2009.
DEA investigation into Oxycodone diversion
In 2008, Cardinal Health agreed to pay $34 million in civil penalties to settle DEA allegations that it failed to report suspicious orders of hydrocodone. The fine followed a 10-month DEA suspension of a Lakeland, Florida distribution facility and two others in New Jersey and Washington. On February 2, 2012, the Drug Enforcement Administration again suspended the license of the firm's Lakeland distribution center to distribute controlled substances on charges that it had allowed four Florida pharmacies to purchase excessive amounts of controlled substances, in particular oxycodone.
Cardinal Health obtained a restraining order against the suspension, but the suspension was upheld on February 29 by a Federal district court because the court agreed with the DEA that Cardinal Health's activities represented an "imminent danger to the public." The company stated that it blocked two of the pharmacies, (Brooks Pharmacy in Bonita Springs, Florida, and Gulf Coast Medical in Panama City, Florida), and notified the corporate owners of the two pharmacies that were part of national chains, two CVS stores in Sanford, Florida.
In February 2012, Joseph Rannazzisi, chief of the Drug Enforcement Administration’s Office of Diversion Control, issued immediate suspension orders against Cardinal's supply of oxycodone to suspected pill mills. These orders were filed after Deputy Attorney General James M. Cole met with Rannazzisi to ask if he had met with Cardinal about the investigation. Cole stated that he believed “it made good sense to listen to what Cardinal had to say” regarding the investigation. That year, Cardinal and the DEA reached a settlement that suspended Cardinal's facility in Lakeland, Florida from selling pain killers or other drugs for two years. In 2016, Cardinal was fined $44 million for after the investigation concluded.
In January 2022, Cardinal Health, Johnson & Johnson, McKesson, and AmerisourceBergen agreed to pay $26 billion to settle with all but five of the states suing them. Had the states gone to court, the companies could have faced up to $95 billion in penalties.
Finances
Annual financial statistics are displayed below:
Cardinal Health Foundation
The Cardinal Health Foundation is the charitable arm of Cardinal Health. The company makes annual product donations of over $9 million through international relief organizations and provides up to $1,000 in matching funds for every Cardinal Health employee that makes a charitable donation. In 2008, the foundation established its E3 Grant Program. Over the past seven years, the Foundation has invested more than $7.15 million in funding to 241 hospitals, health systems or other health-related organizations.
Cardinal Health also supports organizations such as Ronald McDonald House Charities, and was named Benefactor of the Year at the 2011 Corporate Caring Awards. In 2015, the foundation contributed $3 million to the Solutions for Patient Safety project, which has raised over $11 million nationally for efforts to improve safety initiatives in children's hospitals.
Джерело: Wikipedia (Англійська), CC BY-SA 4.0 · Переглянути на Wikipedia ↗
CAH Знімок акцій Ціна, ринкова капіталізація, P/E, EPS, ROE, борг/власний капітал, діапазон 52 тижнів
CAH Графік ціни акцій Денні OHLCV з технічними індикаторами — панування, масштабування та налаштування вашого представлення
10-річна ефективність Тренди виручки, чистого прибутку, маржі та EPS
Оцінка Співвідношення P/E, P/S, P/B, EV/EBITDA — акція дорога чи дешева?
Прибутковість Валова, операційна та чиста маржа; ROE, ROA, ROIC
Фінансове здоровʼя Борг, ліквідність, платоспроможність — міцність балансу
Зростання Зростання виручки, EPS та чистого прибутку: рік до року, 3-річний CAGR, 5-річний CAGR
Ефективність капіталу Оборотність активів, оборотність запасів, оборотність дебіторської заборгованості
Дивіденди Дивідендна дохідність, коефіцієнт виплат, історія дивідендів, 5-річний CAGR
| Дата екс-дивіденду | Сума |
|---|---|
| 01 липня 2026 р. | $0,5160 |
| 01 квітня 2026 р. | $0,5110 |
| 02 січня 2026 р. | $0,5110 |
| 01 жовтня 2025 р. | $0,5110 |
| 01 липня 2025 р. | $0,5110 |
| 01 квітня 2025 р. | $0,5060 |
| 02 січня 2025 р. | $0,5060 |
| 01 жовтня 2024 р. | $0,5060 |
| 01 липня 2024 р. | $0,5060 |
| 28 березня 2024 р. | $0,5010 |
| 29 грудня 2023 р. | $0,5010 |
| 02 жовтня 2023 р. | $0,5010 |
| 30 червня 2023 р. | $0,5010 |
| 31 березня 2023 р. | $0,4960 |
| 30 грудня 2022 р. | $0,4960 |
| 30 вересня 2022 р. | $0,4960 |
| 30 червня 2022 р. | $0,4960 |
| 31 березня 2022 р. | $0,4910 |
| 31 грудня 2021 р. | $0,4910 |
| 30 вересня 2021 р. | $0,4910 |
CAH Консенсус аналітиків Бичачі та ведмежі думки аналітиків, 12-місячна цільова ціна, потенціал зростання
- Активна купівля 8 34,8%
- Купівля 12 52,2%
- Утримувати 3 13,0%
- Продаж 0 0,0%
- Активний продаж 0 0,0%
12-місячна цільова ціна
15 аналітиків · 2026-08-14Історія прибутків EPS фактичний проти прогнозу, сюрприз %, коефіцієнт перевищення, дата наступного звіту про прибутки
| Період | EPS Actual | EPS прогноз | Сюрприз |
|---|---|---|---|
| 31 грудня 2026 р. | $2.91 | $2.44 | 0.47% |
| 30 червня 2026 р. | $2.91 | $2.44 | 0.47% |
| 31 березня 2026 р. | $3.17 | $2.82 | 0.35% |
| 31 грудня 2025 р. | $2.63 | $2.40 | 0.23% |
| 30 вересня 2025 р. | $2.55 | $2.20 | 0.35% |
| 30 червня 2025 р. | $2.08 | $2.06 | 0.02% |
| 31 березня 2025 р. | $2.35 | $2.19 | 0.16% |
Порівняння з аналогами (підгалузь GICS) Ключові показники порівняно з аналогами в секторі
| Тікер | Капіталізація | P/E | Виручка рік до року | Чиста маржа | ROE | Валова маржа |
|---|---|---|---|---|---|---|
| CAH | — | 32.9 | 14.2% | 0.67% | -60.5% | 3.8% |
| MCK | $242.30B | 22.5 | 12.4% | 1.2% | -224.3% | 3.6% |
| COR | $60.61B | 39.3 | 9.3% | 0.48% | 144.3% | 3.6% |
| HSIC | $8.81B | 23.3 | 4.0% | 3.0% | 12.0% | 31.1% |
| AHCO | $1.35B | -19.2 | -0.49% | -2.2% | -4.6% | — |
| ACH | — | — | — | — | — | — |
| MEDS | — | — | — | — | — | — |
Повні фундаментальні показники Усі показники за роками — звіт про прибутки та збитки, баланс, рух грошових коштів
Звіт про прибутки та збитки 15
| Метрика | Тенденція | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B | $162.47B | $152.92B | $145.53B | $136.81B | $129.98B | $121.55B | $102.53B | |
| Cost of Revenue | $244.47B | $214.41B | $219.41B | $198.10B | $174.84B | $155.69B | $146.05B | $138.70B | $129.63B | $123.43B | $115.00B | $96.82B | |
| Gross Profit | $9.77B | $8.17B | $7.41B | $6.87B | $6.48B | $6.78B | $6.87B | $6.83B | $7.18B | $6.54B | $6.54B | $5.71B | |
| SG&A Expense | $6.13B | $5.38B | $5.00B | $4.80B | $4.51B | $4.53B | $4.57B | $4.48B | $4.60B | $3.77B | $3.65B | $3.24B | |
| Operating Income | $2.61B | $2.27B | $1.24B | $752M | $-607M | $472M | $-4.10B | $2.06B | $126M | $2.12B | $2.46B | $2.16B | |
| Interest Expense | $348M | $215M | $51M | $84M | $147M | $180M | $238M | $294M | $329M | $201M | $178M | $141M | |
| Other Non-op | $31M | $41M | $9M | $-5M | $-22M | $47M | $1M | $-15M | $-23M | $5M | $-5M | $7M | |
| Pretax Income | $2.17B | $2.10B | $1.20B | $663M | $-784M | $323M | $-3.77B | $1.75B | $-228M | $1.92B | $2.28B | $1.97B | |
| Income Tax | $469M | $532M | $348M | $332M | $153M | $-289M | $-79M | $386M | $-487M | $630M | $845M | $755M | |
| Net Income | $1.71B | $1.56B | $852M | $330M | $-938M | $611M | $-3.70B | $1.36B | $256M | $1.29B | $1.43B | $1.22B | |
| EPS (Basic) | $7.27 | $6.48 | $3.48 | $1.27 | $-3.37 | $2.09 | $-12.61 | $4.55 | $0.82 | $4.06 | $4.36 | $3.66 | |
| EPS (Diluted) | $7.23 | $6.45 | $3.45 | $1.26 | $-3.37 | $2.08 | $-12.61 | $4.53 | $0.81 | $4.03 | $4.32 | $3.62 | |
| Shares (Basic) | 236,000,000 | 241,000,000 | 245,000,000 | 261,000,000 | 279,000,000 | 292,000,000 | 293,000,000 | 300,000,000 | 313,000,000 | 317,000,000 | 327,000,000 | 332,000,000 | |
| Shares (Diluted) | 237,000,000 | 242,000,000 | 247,000,000 | 262,000,000 | 279,000,000 | 294,000,000 | 293,000,000 | 301,000,000 | 315,000,000 | 320,000,000 | 330,000,000 | 335,000,000 | |
| EBITDA | $3.57B | $3.06B | $1.95B | $1.42B | $96M | $1.25B | $-3.19B | $3.06B | $1.16B | $2.84B | $3.10B | $2.61B |
Баланс 25
| Метрика | Тенденція | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.86B | $3.87B | $5.13B | $4.08B | $4.72B | $3.41B | $2.77B | $2.53B | $1.76B | $6.88B | $2.36B | $4.62B | |
| Short-term Investments | · | · | $200M | · | · | · | · | · | · | $65M | $113M | $91M | |
| Receivables | $13.81B | $13.24B | $12.08B | $11.11B | $10.56B | $9.10B | $8.26B | $8.45B | $7.80B | $8.05B | $7.41B | $6.52B | |
| Inventory | $17.30B | $16.83B | $14.96B | $16.12B | $15.64B | $14.59B | $13.20B | $12.82B | $12.31B | $11.30B | $10.62B | $9.21B | |
| Other Current Assets | $2.76B | $2.41B | $2.66B | $2.29B | $2.02B | $2.84B | $1.71B | $1.95B | $1.93B | $2.12B | $1.58B | $1.40B | |
| Current Assets | $38.75B | $36.37B | $34.88B | $33.74B | $32.94B | $31.05B | $25.94B | $25.75B | $24.55B | $28.34B | $21.96B | $21.75B | |
| PP&E (Net) | $3.03B | $2.86B | $2.53B | $2.46B | $2.36B | $2.36B | $2.37B | $2.36B | $2.49B | $1.88B | $1.80B | $1.51B | |
| PP&E (Gross) | $7.97B | $7.52B | $6.70B | $6.31B | $5.88B | $5.59B | $5.33B | $5.17B | $5.26B | $4.63B | $4.48B | $4.03B | |
| Accum. Depreciation | $4.93B | $4.66B | $4.17B | $3.85B | $3.52B | $3.23B | $2.96B | $2.81B | $2.77B | $2.75B | $2.68B | $2.53B | |
| Goodwill | $11.44B | $9.69B | $4.72B | $4.61B | $5.86B | $7.99B | $8.36B | $8.38B | $8.32B | $7.22B | $7.17B | $5.07B | |
| Intangibles | $2.19B | $2.49B | $1.73B | $1.47B | $1.77B | $2.10B | $2.92B | $3.43B | $3.91B | $1.99B | $1.99B | $948M | |
| Other Non-current Assets | $1.88B | $1.71B | $1.26B | $1.07B | $953M | $951M | $1.19B | $1.05B | $682M | $681M | $944M | $866M | |
| Total Assets | $57.30B | $53.12B | $45.12B | $43.35B | $43.88B | $44.45B | $40.77B | $40.96B | $39.95B | $40.11B | $34.12B | $30.14B | |
| Accounts Payable | $38.28B | $34.71B | $31.76B | $29.93B | $27.13B | $23.70B | $21.37B | $21.54B | $19.68B | $17.91B | $17.31B | $14.37B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | $855M | $0 | $0 | |
| Current Liabilities | $43.90B | $38.90B | $35.64B | $33.74B | $30.55B | $27.62B | $23.61B | $24.11B | $22.89B | $21.22B | $19.70B | $17.24B | |
| Capital Leases | $861M | $654M | $400M | $375M | $388M | $374M | $341M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | $1.75B | $1.81B | $1.95B | $1.70B | $328M | |
| Total Debt | · | · | · | · | · | · | · | · | · | $855M | $0 | · | |
| Common Stock | $2.89B | $2.96B | $2.92B | $2.75B | $2.81B | $2.81B | $2.79B | $2.76B | $2.73B | $2.70B | $3.01B | $3.00B | |
| Retained Earnings | $2.01B | $783M | $-286M | $-642M | $-280M | $1.21B | $1.17B | $5.43B | $4.64B | $4.97B | $6.42B | $5.52B | |
| Treasury Stock | $7.61B | $6.37B | $5.68B | $4.91B | $3.13B | $2.19B | $2.07B | $1.79B | $1.22B | $731M | $2.76B | $2.25B | |
| AOCI | $-165M | $-155M | $-167M | $-151M | $-114M | $-34M | $-104M | $-79M | $-92M | $-125M | $-116M | $-23M | |
| Stockholders' Equity | $-2.88B | $-2.78B | $-3.21B | $-2.96B | $-709M | $1.79B | $1.79B | $6.33B | $6.06B | $6.81B | $6.55B | $6.26B | |
| Liabilities + Equity | $57.30B | $53.12B | $45.12B | $43.35B | $43.88B | $44.45B | $40.77B | $40.96B | $39.95B | $40.11B | $34.12B | $30.14B |
Грошовий потік 19
| Метрика | Тенденція | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $956M | $790M | $710M | $692M | $692M | $783M | $913M | $1.00B | $1.03B | $717M | $641M | $451M | |
| Stock-based Comp | $367M | $244M | $121M | $96M | $81M | $89M | $90M | $82M | $85M | $96M | $111M | $110M | |
| Deferred Tax | $91M | $243M | $-104M | $-40M | $14M | $496M | $-961M | $-83M | $-1.01B | $291M | $87M | $219M | |
| Amort. of Intangibles | $361M | $303M | $264M | $281M | $311M | $428M | $512M | $531M | $574M | $395M | $355M | $191M | |
| Restructuring | $106M | $88M | $175M | $95M | $101M | $114M | $122M | $125M | $176M | $56M | $25M | $44M | |
| Other Non-cash | $2.05B | $-441M | $2.18B | $1.82B | $3.27B | $450M | $5.61B | $360M | $2.41B | · | $705M | $545M | |
| Operating Cash Flow | $5.17B | $2.40B | $3.76B | $2.84B | $3.17B | $2.43B | $1.96B | $2.72B | $2.77B | $1.18B | $2.97B | $2.54B | |
| CapEx | $649M | $547M | $511M | $481M | $387M | $400M | $375M | $328M | $384M | $387M | $465M | $300M | |
| Investing Cash Flow | $-2.58B | $-5.59B | $-1.85B | $-454M | $567M | $-378M | $493M | $338M | $-5.61B | $-405M | $-4.08B | $-849M | |
| Debt Issued | $1.00B | $2.90B | $1.14B | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $347M | $2.46B | $357M | $-579M | $-885M | $-570M | $-1.40B | $-1.10B | $-954M | $-310M | $-6M | $-1.22B | |
| Stock Repurchased | $1.36B | $765M | $750M | $2.00B | $1.00B | $200M | $350M | $600M | $550M | $600M | $651M | $1.04B | |
| Net Stock Activity | $-1.36B | $-765M | $-750M | $-2.00B | $-1.00B | $-200M | $-350M | $-600M | $-550M | $-600M | $-651M | $-1.04B | |
| Dividends Paid | $491M | $494M | $499M | $525M | $559M | $573M | $569M | $577M | $581M | $577M | $512M | $460M | |
| Financing Cash Flow | $-1.60B | $1.94B | $-847M | $-3.05B | $-2.46B | $-1.32B | $-2.20B | $-2.29B | $-2.28B | $3.75B | $-1.14B | $60M | |
| Net Change in Cash | $982M | $-1.26B | $1.06B | $-669M | $1.36B | $636M | $240M | $768M | $-5.12B | $4.52B | $-2.26B | $1.75B | |
| Taxes Paid | $338M | $444M | $191M | $156M | $-766M | $273M | $368M | $311M | $425M | $686M | $635M | $529M | |
| Free Cash Flow | $4.53B | $1.85B | $3.25B | $2.36B | $2.73B | $2.03B | $1.58B | $2.39B | $2.38B | $797M | $2.51B | $2.24B | |
| Levered FCF | $4.25B | $1.69B | $3.21B | $2.32B | $2.55B | $1.69B | $1.35B | $2.16B | $2.76B | $662M | $2.39B | $2.15B |
Прибутковість 8
| Метрика | Тенденція | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.8% | 3.7% | 3.3% | 3.4% | 3.6% | 4.2% | 4.5% | 4.7% | 5.2% | 5.0% | 5.4% | 5.6% | |
| Operating Margin | 1.0% | 1.0% | 0.55% | 0.35% | -0.33% | 0.29% | -2.7% | 1.4% | 0.09% | 1.6% | 2.0% | 2.1% | |
| Net Margin | 0.67% | 0.70% | 0.38% | 0.13% | -0.51% | 0.38% | -2.4% | 0.94% | 0.19% | · | 1.2% | 1.2% | |
| Pretax Margin | 0.86% | 0.94% | 0.53% | 0.31% | -0.42% | 0.20% | -2.5% | 1.2% | -0.17% | 1.5% | 1.9% | 1.9% | |
| EBITDA Margin | 1.4% | 1.4% | 0.86% | 0.69% | 0.05% | 0.77% | -2.1% | 2.1% | 0.85% | 2.2% | 2.5% | 2.5% | |
| ROA | 3.1% | 3.2% | 1.9% | 0.60% | -2.1% | 1.4% | -9.0% | 3.4% | 0.64% | · | 4.4% | 4.3% | |
| ROE | -60.5% | -52.1% | -27.6% | -14.7% | -172.5% | 34.1% | -91.1% | 22.0% | 4.0% | · | 22.3% | 19.2% | |
| ROIC | -71.1% | -61.1% | -27.5% | -10.5% | 101.9% | 49.9% | -224.3% | 25.4% | -2.4% | 18.6% | 23.6% | 21.3% |
Ліквідність та платоспроможність 4
| Метрика | Тенденція | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 1.0 | 1.0 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.3 | 1.1 | 1.3 | |
| Quick Ratio | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.7 | 0.5 | 0.7 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | 0.1 | 0.0 | · | |
| Interest Coverage | 7.5 | 10.6 | 24.4 | 7.8 | -4.0 | 2.6 | -17.2 | 7.0 | 0.4 | 10.5 | 13.8 | 15.3 |
Ефективність 3
| Метрика | Тенденція | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 4.6 | 4.5 | 5.1 | 4.7 | 4.1 | 3.8 | 3.7 | 3.6 | 3.4 | 3.5 | 3.8 | 3.7 | |
| Inventory Turnover | 14.3 | 13.5 | 14.1 | 12.5 | 11.6 | 11.2 | 11.2 | 11.0 | 11.0 | 11.3 | 11.6 | 11.1 | |
| Receivables Turnover | 18.8 | 17.6 | 19.6 | 18.7 | 18.4 | 18.7 | 18.3 | 17.9 | 17.3 | 16.8 | 17.5 | 17.2 |
Темпи зростання 10
| Метрика | Тенденція | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 14.2% | -1.9% | 10.7% | 13.0% | 11.6% | 6.2% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.4% | 7.1% | 11.8% | 10.3% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 9.4% | 7.8% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 12.1% | 87.0% | 173.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 79.0% | · | 18.4% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 28.3% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 9.8% | 83.2% | 158.2% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 73.2% | · | 11.7% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 22.9% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | -3.0% | -2.8% | · | · | · | · | · | · | · | · | · | · |
Оцінка (TTM) 6
| Метрика | Тенденція | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B | $162.47B | $152.92B | $145.53B | $136.81B | $129.98B | $121.55B | $102.53B | |
| Net Income TTM | $1.71B | $1.56B | $852M | $330M | $-938M | $611M | $-3.70B | $1.36B | $256M | $1.29B | $1.43B | $1.22B | |
| P/E | 32.9 | 26.0 | 28.5 | 75.1 | -15.5 | 27.4 | -4.1 | 10.4 | 60.3 | 19.3 | 18.1 | 23.1 | |
| Earnings Yield | 3.0% | 3.8% | 3.5% | 1.3% | -6.5% | 3.6% | -24.2% | 9.6% | 1.7% | 5.2% | 5.5% | 4.3% | |
| Payout Ratio | 28.6% | 31.6% | 58.6% | 201.1% | -59.9% | 93.8% | -15.4% | 42.3% | 226.9% | · | 35.9% | 37.9% | |
| Annual Payout | $491M | $494M | $499M | $525M | $559M | $573M | $569M | $577M | $581M | $577M | $512M | $460M |
Звіт про прибутки та збитки 15
| Метрика | Тенденція | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $63.67B | $60.94B | $65.63B | $64.01B | $60.16B | $54.88B | $55.26B | $52.28B | $59.87B | $54.87B | $57.44B | $54.65B | $53.42B | $50.50B | $51.47B | $49.59B | |
| Cost of Revenue | $61.11B | $58.44B | $63.23B | $61.69B | $57.96B | $52.76B | $53.32B | $50.38B | $57.98B | $52.93B | $55.59B | $52.91B | $51.61B | $48.69B | $49.78B | $48.00B | |
| Gross Profit | $2.56B | $2.50B | $2.40B | $2.32B | $2.20B | $2.12B | $1.94B | $1.90B | $1.88B | $1.94B | $1.85B | $1.74B | $1.81B | $1.81B | $1.68B | $1.60B | |
| SG&A Expense | $1.62B | $1.54B | $1.50B | $1.46B | $1.48B | $1.31B | $1.31B | $1.28B | $1.28B | $1.27B | $1.27B | $1.19B | $1.23B | $1.17B | $1.18B | $1.20B | |
| Operating Income | $729M | $509M | $707M | $668M | $428M | $730M | $549M | $568M | $401M | $369M | $505M | $-32M | $162M | $604M | $-86M | $123M | |
| Interest Expense | · | · | $88M | $80M | $74M | $74M | $35M | $32M | $9M | $28M | $3M | $11M | $6M | $26M | $24M | $24M | |
| Other Non-op | $26M | $-16M | $11M | $10M | $30M | $9M | $-3M | $5M | $-1M | $1M | $10M | $-1M | $-10M | $-2M | $6M | $-3M | |
| Pretax Income | $554M | $392M | $630M | $598M | $384M | $665M | $511M | $541M | $391M | $342M | $512M | $-44M | $146M | $576M | $-104M | $96M | |
| Income Tax | $154M | $12M | $159M | $144M | $141M | $157M | $110M | $124M | $158M | $80M | $143M | $-33M | $143M | $209M | $-27M | $-3M | |
| Net Income | $398M | $399M | $467M | $450M | $239M | $506M | $400M | $416M | $235M | $261M | $368M | $-12M | $5M | $365M | $-77M | $98M | |
| EPS (Basic) | · | · | · | $1.89 | · | · | · | $1.71 | · | $1.07 | $1.50 | $-0.05 | · | $1.43 | $-0.30 | $0.36 | |
| EPS (Diluted) | · | · | · | $1.88 | · | · | · | $1.70 | · | $1.07 | $1.50 | $-0.05 | · | $1.41 | $-0.30 | $0.36 | |
| Shares (Basic) | -473,000,000 | 235,000,000 | 236,000,000 | 238,000,000 | -484,000,000 | 240,000,000 | 242,000,000 | 243,000,000 | -492,000,000 | 243,000,000 | 245,000,000 | 249,000,000 | -527,000,000 | 256,000,000 | 261,000,000 | 271,000,000 | |
| Shares (Diluted) | -475,000,000 | 236,000,000 | 237,000,000 | 239,000,000 | -487,000,000 | 241,000,000 | 243,000,000 | 245,000,000 | -493,000,000 | 245,000,000 | 246,000,000 | 249,000,000 | -530,000,000 | 258,000,000 | 261,000,000 | 273,000,000 | |
| EBITDA | · | $757M | $941M | $901M | · | $730M | $549M | $750M | · | $367M | $482M | $158M | · | $572M | $-119M | $308M |
Баланс 21
| Метрика | Тенденція | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.86B | $3.94B | $2.78B | $4.59B | $3.87B | $3.33B | $3.81B | $2.87B | $5.13B | $3.72B | $4.59B | $3.85B | · | $3.99B | $3.65B | $3.49B | |
| Receivables | $13.81B | $13.65B | $13.66B | $13.77B | $13.24B | $12.67B | $12.37B | $11.78B | $12.08B | $11.57B | $11.79B | $11.27B | · | $10.99B | $11.42B | $11.04B | |
| Inventory | $17.30B | $18.01B | $20.12B | $17.56B | $16.83B | $16.16B | $16.90B | $15.62B | $14.96B | $17.28B | $18.45B | $16.99B | · | $16.62B | $17.26B | $15.89B | |
| Other Current Assets | $2.76B | $2.47B | $2.67B | $2.60B | $2.41B | $2.40B | $2.62B | $2.59B | $2.66B | $3.16B | $2.82B | $2.58B | · | $1.90B | $2.26B | $2.27B | |
| Current Assets | $38.75B | $38.06B | $39.23B | $38.54B | $36.37B | $34.59B | $35.76B | $32.91B | $34.88B | $35.73B | $37.66B | $34.69B | · | $33.50B | $34.60B | $32.70B | |
| PP&E (Net) | $3.03B | $2.93B | $2.88B | $2.83B | $2.86B | $2.66B | $2.56B | $2.54B | $2.53B | $2.47B | $2.45B | $2.44B | · | $2.36B | $2.34B | $2.34B | |
| PP&E (Gross) | $7.97B | · | · | · | $7.52B | · | · | · | $6.70B | · | · | · | · | · | · | · | |
| Accum. Depreciation | $4.93B | · | · | · | $4.66B | · | · | · | $4.17B | · | · | · | · | · | · | · | |
| Goodwill | $11.44B | $11.41B | $11.61B | $9.71B | $9.69B | $8.91B | $5.49B | $4.72B | $4.72B | $4.79B | $4.02B | $4.03B | $4.61B | $5.00B | $4.99B | $5.67B | |
| Intangibles | $2.19B | $2.28B | $2.37B | $2.40B | $2.49B | $2.11B | $1.95B | $1.66B | $1.73B | $1.72B | $1.35B | $1.41B | · | $1.57B | $1.63B | $1.69B | |
| Other Non-current Assets | $1.88B | $2.00B | $2.00B | $1.75B | $1.71B | $1.60B | $1.25B | $1.23B | $1.26B | $1.17B | $1.10B | $1.15B | · | $951M | $927M | $985M | |
| Total Assets | $57.30B | $56.69B | $58.08B | $55.23B | $53.12B | $49.87B | $47.00B | $43.06B | $45.12B | $45.88B | $46.57B | $43.71B | · | $43.38B | $44.48B | $43.39B | |
| Accounts Payable | $38.28B | $37.83B | $39.00B | $36.86B | $34.71B | $32.81B | $31.30B | $30.36B | $31.76B | $32.09B | $34.26B | $31.54B | · | $29.60B | $30.08B | $28.36B | |
| Current Liabilities | $43.90B | $41.99B | $43.31B | $40.27B | $38.90B | $36.66B | $35.22B | $34.68B | $35.64B | $36.31B | $38.29B | $35.06B | · | $32.50B | $33.21B | $31.56B | |
| Capital Leases | $861M | · | · | · | $654M | · | · | · | $400M | · | · | · | · | · | · | · | |
| Common Stock | $2.89B | $2.81B | $2.85B | $2.75B | $2.96B | $2.95B | $2.93B | $2.83B | $2.92B | $2.89B | $2.85B | $2.73B | · | $2.82B | $2.75B | $2.58B | |
| Retained Earnings | $2.01B | $1.73B | $1.46B | $1.12B | $783M | $664M | $283M | $14M | $-286M | $-289M | $-425M | $-654M | · | $-342M | $-560M | $-301M | |
| Treasury Stock | $7.61B | $7.22B | $7.03B | $6.58B | $6.37B | $6.38B | $6.03B | $5.96B | $5.68B | $5.70B | $5.72B | $5.40B | $4.91B | $4.55B | $4.25B | $3.88B | |
| AOCI | $-165M | $-161M | $-153M | $-159M | $-155M | $-176M | $-180M | $-155M | $-167M | $-160M | $-155M | $-165M | · | $-142M | $-146M | $-176M | |
| Stockholders' Equity | $-2.88B | $-2.83B | $-2.88B | $-2.88B | $-2.78B | $-2.95B | $-2.99B | $-3.28B | $-3.21B | $-3.27B | $-3.45B | $-3.49B | · | $-2.22B | $-2.21B | $-1.78B | |
| Liabilities + Equity | $57.30B | $56.69B | $58.08B | $55.23B | $53.12B | $49.87B | $47.00B | $43.06B | $45.12B | $45.88B | $46.57B | $43.71B | · | $43.38B | $44.48B | $43.39B |
Грошовий потік 17
| Метрика | Тенденція | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $241M | $248M | $234M | $233M | $209M | $207M | $192M | $182M | $186M | $177M | $175M | $172M | $176M | $175M | $170M | $171M | |
| Stock-based Comp | $58M | $129M | $87M | $93M | $153M | $31M | $30M | $30M | $33M | $31M | $28M | $29M | $27M | $21M | $25M | $23M | |
| Amort. of Intangibles | $95M | $95M | $84M | $87M | $89M | $77M | $69M | $68M | $73M | $64M | $63M | $64M | $70M | $69M | $71M | $71M | |
| Restructuring | $40M | $25M | $21M | $20M | $27M | $28M | $9M | $24M | $69M | $53M | $28M | $25M | $33M | $16M | $17M | $29M | |
| Other Non-cash | · | · | · | $197M | · | · | · | $-2.27B | · | · | · | $339M | · | · | · | $-281M | |
| Operating Cash Flow | $1.69B | $1.82B | $686M | $973M | $1.52B | $2.92B | $-396M | $-1.65B | $2.08B | $-54M | $1.16B | $528M | $863M | $1.36B | $597M | $23M | |
| CapEx | $264M | $146M | $131M | $108M | $232M | $126M | $99M | $90M | $193M | $112M | $114M | $92M | $217M | $109M | $85M | $70M | |
| Investing Cash Flow | $-281M | $-181M | $-1.98B | $-142M | $-1.63B | $-2.90B | $-976M | $-88M | $166M | $-1.85B | $-105M | $-63M | $-206M | $-91M | $-87M | $-70M | |
| Debt Issued | $0 | $0 | $0 | $1.00B | $0 | $0 | · | · | $0 | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | $488M | · | · | · | $-9M | · | · | · | $-7M | · | · | · | $-7M | |
| Stock Repurchased | $350M | $250M | $383M | $375M | $0 | $375M | $15M | $375M | $0 | $0 | $250M | $500M | $500M | $250M | $250M | $1.00B | |
| Net Stock Activity | · | · | · | $-375M | · | · | · | $-375M | · | · | · | $-500M | · | · | · | $-1.00B | |
| Dividends Paid | $120M | $120M | $122M | $129M | $120M | $124M | $122M | $128M | $122M | $122M | $124M | $131M | $126M | $128M | $129M | $142M | |
| Financing Cash Flow | $-490M | $-483M | $-519M | $-110M | $663M | $-507M | $2.33B | $-540M | $-859M | $1.03B | $-353M | $-666M | $-592M | $-934M | $-362M | $-1.16B | |
| Net Change in Cash | $919M | $1.16B | $-1.82B | $719M | $548M | $-484M | $943M | $-2.27B | $1.39B | $-878M | $710M | $-206M | $58M | $336M | $162M | $-1.23B | |
| Free Cash Flow | · | · | · | $865M | · | · | · | $-1.74B | · | · | · | $453M | · | · | · | $-47M | |
| Levered FCF | · | · | · | $804M | · | · | · | $-1.76B | · | · | · | $456M | · | · | · | $-72M |
Прибутковість 8
| Метрика | Тенденція | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 4.1% | 3.6% | 3.6% | · | 3.9% | 3.5% | 3.6% | · | 3.5% | 3.2% | 3.2% | · | 3.5% | 3.2% | 3.2% | |
| Operating Margin | · | 0.84% | 1.1% | 1.0% | · | 1.3% | 0.99% | 1.1% | · | 0.67% | 0.84% | -0.03% | · | 1.1% | -0.23% | 0.28% | |
| Net Margin | · | 0.65% | 0.71% | 0.70% | · | 0.92% | 0.72% | 0.80% | · | 0.47% | 0.61% | 0.01% | · | 0.68% | -0.25% | 0.22% | |
| Pretax Margin | · | 0.64% | 0.96% | 0.93% | · | 1.2% | 0.92% | 1.0% | · | 0.62% | 0.85% | -0.05% | · | 1.1% | -0.27% | 0.22% | |
| EBITDA Margin | · | 1.2% | 1.4% | 1.4% | · | 1.3% | 0.99% | 1.4% | · | 0.67% | 0.84% | 0.29% | · | 1.1% | -0.23% | 0.62% | |
| ROA | · | 0.75% | 0.89% | 0.92% | · | 1.1% | 0.85% | 0.96% | · | 0.58% | 0.78% | 0.01% | · | 0.81% | -0.29% | 0.25% | |
| ROE | · | -13.8% | -15.9% | -14.6% | · | -16.3% | -12.4% | -12.3% | · | -9.4% | -12.5% | -0.19% | · | -23.6% | 21.4% | -56.7% | |
| ROIC | · | -17.4% | -18.3% | -17.6% | · | -18.9% | -14.4% | -13.4% | · | -8.5% | -10.1% | -0.09% | · | -16.4% | 5.1% | -7.8% |
Ліквідність та платоспроможність 3
| Метрика | Тенденція | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 0.9 | 0.9 | 1.0 | · | 0.9 | 1.0 | 0.9 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | |
| Quick Ratio | · | 0.4 | 0.4 | 0.5 | · | 0.4 | 0.5 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | |
| Interest Coverage | · | · | 8.0 | 8.3 | · | 9.9 | 15.7 | 17.8 | · | 11.1 | 60.2 | -1.0 | · | 20.4 | -4.8 | 5.5 |
Ефективність 3
| Метрика | Тенденція | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 1.1 | 1.2 | 1.3 | · | 1.1 | 1.2 | 1.2 | · | 1.2 | 1.3 | 1.3 | · | 1.2 | 1.2 | 1.1 | |
| Inventory Turnover | · | 3.4 | 3.4 | 3.7 | · | 3.2 | 3.0 | 3.1 | · | 3.1 | 3.1 | 3.2 | · | 3.0 | 3.1 | 3.1 | |
| Receivables Turnover | · | 4.6 | 5.0 | 5.0 | · | 4.5 | 4.6 | 4.5 | · | 4.9 | 5.0 | 4.9 | · | 4.8 | 4.9 | 4.9 |
Оцінка (TTM) 5
| Метрика | Тенденція | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $245.45B | $239.78B | $226.43B | · | $217.29B | $219.85B | $219.24B | · | $217.46B | $214.06B | $206.21B | · | $196.39B | $191.35B | $183.85B | |
| Net Income TTM | · | $1.82B | $1.82B | $1.77B | · | $1.58B | $1.45B | $1.03B | · | $982M | $644M | $374M | · | $-1.00B | $-1.32B | $-973M | |
| P/E | · | · | · | · | · | 32.6 | 28.0 | 26.2 | · | 28.5 | 39.4 | 61.1 | · | · | · | · | |
| Earnings Yield | · | · | · | · | · | 3.1% | 3.6% | 3.8% | · | 3.5% | 2.5% | 1.6% | · | · | · | · | |
| Payout Ratio | · | · | · | 28.7% | · | · | · | 30.8% | · | · | · | 2620.0% | · | · | · | 129.1% |
Фінансова звітність Звіт про прибутки та збитки, баланс, рух грошових коштів — річні, за останні 5 років
Звіт про прибутки та збитки
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|
| Виручка | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B |
| Валова маржа % | 3.8% | 3.7% | 3.3% | 3.4% | 3.6% |
| Операційна маржа % | 1.0% | 1.0% | 0.55% | 0.35% | -0.33% |
| Чистий прибуток | $1.71B | $1.56B | $852M | $330M | $-938M |
| Розбавлений EPS | $7.23 | $6.45 | $3.45 | $1.26 | $-3.37 |
Баланс
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|
| Поточний коефіцієнт | 0.9 | 0.9 | 1.0 | 1.0 | 1.1 |
| Коефіцієнт швидкої ліквідності | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 |
Грошовий потік
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|
| Вільний грошовий потік | $4.53B | $1.85B | $3.25B | $2.36B | $2.73B |
Останні новини Останні заголовки, що згадують цю компанію
Мої показники Ваш персональний список спостереження — вибрані рядки з Повних фундаментальних даних
Виберіть показники, які для вас важливі — натисніть ➕ поруч із будь-яким рядком у Повних фундаментальних даних вище.
Ваш вибір збережено і він буде застосовуватися до всіх тікерів.
Інституційні власники (13F) 1 618 подавачів звітності · $31.0B всього · Станом на 30 червня 2026 р.
Інституційні інвестори, які звітують про володіння цими акціями у своїй квартальній формі SEC 13F. Тільки довгі позиції; один подавець звітності може з'явитися двічі для окремих опціонних контрактів. Великі протилежні опціонні позиції (пут/кол) зазвичай відображають маркет-мейкінг або хеджування запасів, а не спрямованість переконань.
| Нові позиції | Закриті позиції | Збільшено | Зменшено | Зміна чистих акцій |
|---|---|---|---|---|
| 162 (-12 проти попереднього кв.) | 80 (-20 проти попереднього кв.) | 516 (-30 проти попереднього кв.) | 545 (+38 проти попереднього кв.) | +35.4M |
Порівняно з Q1 2026. Звіти SEC Form 13F подаються протягом 45 днів після закінчення кварталу плюс невеликий буфер для тих, хто подає із запізненням — квартали, що ще знаходяться в цьому вікні, пропускаються на користь останньої повністю звітної пари.
| Інституційний інвестор | Вартість | Акції | % від відстежуваного 13F | Тип |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $3 632 811 706 | 15 292 186 | 11,74% | Акції |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3 258 822 899 | 13 717 894 | 10,53% | Акції |
| WELLINGTON MANAGEMENT GROUP LLP | $3 254 296 668 | 13 698 841 | 10,51% | Акції |
| STATE STREET CORP | $2 842 909 265 | 11 967 121 | 9,18% | Акції |
| GEODE CAPITAL MANAGEMENT, LLC | $1 350 305 229 | 5 709 017 | 4,36% | Акції |
| WCM INVESTMENT MANAGEMENT, LLC | $971 445 537 | 4 112 461 | 3,14% | Акції |
| NORGES BANK | $885 248 810 | 3 726 422 | 2,86% | Акції |
| BNP PARIBAS FINANCIAL MARKETS | $499 624 076 | 2 103 149 | 1,61% | Акції |
| VICTORY CAPITAL MANAGEMENT INC | $469 793 667 | 1 977 579 | 1,52% | Акції |
| VANGUARD FIDUCIARY TRUST CO | $315 702 986 | 1 328 940 | 1,02% | Акції |
| VANGUARD GROUP INC | $277 003 725 | 1 347 950 | 0,89% | Акції |
| Robeco Institutional Asset Management B.V. | $258 918 781 | 1 089 909 | 0,84% | Акції |
| DIMENSIONAL FUND ADVISORS LP | $244 584 818 | 1 029 571 | 0,79% | Акції |
| ENVESTNET ASSET MANAGEMENT INC | $230 523 823 | 970 390 | 0,74% | Акції |
| BlackRock, Inc. | $225 912 433 | 950 970 | 0,73% | Акції |
| Man Group plc | $220 862 620 | 929 713 | 0,71% | Акції |
| FMR LLC | $211 855 495 | 891 798 | 0,68% | Акції |
| GOLDMAN SACHS GROUP INC | $199 229 035 | 838 647 | 0,64% | Акції |
| ProShare Advisors LLC | $197 187 154 | 830 052 | 0,64% | Акції |
| NORDEA INVESTMENT MANAGEMENT AB | $192 568 890 | 809 283 | 0,62% | Акції |
| Legal & General Group Plc | $184 918 605 | 778 408 | 0,60% | Акції |
| JANE STREET GROUP, LLC | $169 712 864 | 714 400 | 0,55% | Опціон кол |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $160 043 538 | 677 519 | 0,52% | Акції |
| Swiss National Bank | $157 644 816 | 663 600 | 0,51% | Акції |
| JANE STREET GROUP, LLC | $153 701 320 | 647 000 | 0,50% | Опціон пут |
| Mitsubishi UFJ Asset Management Co., Ltd. | $141 722 832 | 596 577 | 0,46% | Акції |
| 1832 Asset Management L.P. | $139 039 117 | 585 280 | 0,45% | Акції |
| Sumitomo Mitsui Trust Group, Inc. | $132 703 867 | 558 612 | 0,43% | Акції |
| RENAISSANCE TECHNOLOGIES LLC | $130 681 756 | 550 100 | 0,42% | Акції |
| BANK OF AMERICA CORP /DE/ | $126 454 568 | 532 306 | 0,41% | Акції |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $123 081 499 | 518 107 | 0,40% | Акції |
| Vanguard Global Advisers, LLC | $122 136 010 | 514 127 | 0,39% | Акції |
| LPL Financial LLC | $120 559 117 | 507 489 | 0,39% | Акції |
| RHUMBLINE ADVISERS | $116 899 342 | 492 084 | 0,38% | Акції |
| UBS Group AG | $116 739 360 | 491 410 | 0,38% | Акції |
| National Pension Service | $113 432 762 | 477 491 | 0,37% | Акції |
| FRED ALGER MANAGEMENT, LLC | $111 665 316 | 470 051 | 0,36% | Акції |
| SEI INVESTMENTS CO | $110 593 700 | 465 540 | 0,36% | Акції |
| VANGUARD ASSET MANAGEMENT, Ltd | $109 533 215 | 461 076 | 0,35% | Акції |
| BARCLAYS PLC | $108 067 946 | 454 908 | 0,35% | Акції |
| LAZARD ASSET MANAGEMENT LLC | $106 528 318 | 448 427 | 0,34% | Акції |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $104 481 026 | 439 809 | 0,34% | Акції |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $104 081 450 | 438 127 | 0,34% | Акції |
| California Public Employees Retirement System | $103 583 999 | 436 033 | 0,33% | Акції |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $101 984 508 | 429 300 | 0,33% | Опціон кол |
| TWO SIGMA ADVISERS, LP | $96 441 150 | 469 300 | 0,31% | Акції |
| JANUS HENDERSON GROUP PLC | $96 030 102 | 454 526 | 0,31% | Акції |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $95 040 000 | 400 069 | 0,31% | Акції |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $94 526 074 | 397 904 | 0,31% | Акції |
| ING GROEP NV | $90 805 885 | 382 244 | 0,29% | Акції |
| Retirement Systems of Alabama | $89 453 931 | 376 553 | 0,29% | Акції |
| BANK OF NOVA SCOTIA | $88 870 008 | 374 095 | 0,29% | Акції |
| RAYMOND JAMES FINANCIAL INC | $88 654 749 | 373 189 | 0,29% | Акції |
| Artemis Investment Management LLP | $87 745 162 | 369 360 | 0,28% | Акції |
| TD Asset Management Inc | $85 393 555 | 359 461 | 0,28% | Акції |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $85 236 528 | 358 800 | 0,28% | Опціон пут |
| Delta Accumulation, LLC | $81 886 932 | 344 700 | 0,26% | Опціон пут |
| STOREBRAND ASSET MANAGEMENT AS | $80 500 769 | 338 865 | 0,26% | Акції |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $79 269 258 | 333 681 | 0,26% | Акції |
| ROYAL BANK OF CANADA | $79 026 000 | 332 656 | 0,26% | Акції |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $78 334 941 | 370 711 | 0,25% | Акції |
| Ensign Peak Advisors, Inc | $78 327 333 | 329 716 | 0,25% | Акції |
| GFS Advisors, LLC | $76 777 103 | 55 | 0,25% | Акції |
| Integral Health Asset Management, LLC | $71 268 000 | 300 000 | 0,23% | Акції |
| Focus Partners Wealth | $69 563 786 | 292 826 | 0,22% | Акції |
| ZACKS INVESTMENT MANAGEMENT | $69 526 717 | 292 669 | 0,22% | Акції |
| PRUDENTIAL FINANCIAL INC | $69 141 838 | 291 050 | 0,22% | Акції |
| FIRST TRUST ADVISORS LP | $63 253 014 | 266 262 | 0,20% | Акції |
| Caisse de depot et placement du Quebec | $63 072 655 | 265 502 | 0,20% | Акції |
| MILLENNIUM MANAGEMENT LLC | $60 514 609 | 254 734 | 0,20% | Акції |
| CANADA PENSION PLAN INVESTMENT BOARD | $60 313 158 | 253 886 | 0,19% | Акції |
| Gotham Asset Management, LLC | $59 744 915 | 251 494 | 0,19% | Акції |
| NATIXIS | $57 996 711 | 244 135 | 0,19% | Акції |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $57 683 884 | 243 678 | 0,19% | Акції |
| AMERIPRISE FINANCIAL INC | $56 823 880 | 239 198 | 0,18% | Акції |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $56 038 504 | 235 892 | 0,18% | Акції |
| ALLIANCEBERNSTEIN L.P. | $55 998 840 | 265 008 | 0,18% | Акції |
| Vest Financial, LLC | $55 494 016 | 233 600 | 0,18% | Акції |
| AVIVA PLC | $54 653 054 | 230 060 | 0,18% | Акції |
| COOKSON PEIRCE & CO INC | $54 112 422 | 227 784 | 0,17% | Акції |
| APG Asset Management N.V. | $52 132 088 | 250 895 | 0,17% | Акції |
| Delta Accumulation, LLC | $50 101 404 | 210 900 | 0,16% | Опціон кол |
| Quantinno Capital Management LP | $49 716 731 | 209 280 | 0,16% | Акції |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $48 954 227 | 206 071 | 0,16% | Акції |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $48 870 606 | 205 719 | 0,16% | Акції |
| Zurich Insurance Group Ltd/FI | $47 315 063 | 199 171 | 0,15% | Акції |
| CRAWFORD INVESTMENT COUNSEL INC | $45 812 739 | 192 847 | 0,15% | Акції |
| Cetera Investment Advisers | $45 437 576 | 191 268 | 0,15% | Акції |
| Empyrean Capital Partners, LP | $43 758 552 | 184 200 | 0,14% | Акції |
| Squarepoint Ops LLC | $43 560 427 | 183 366 | 0,14% | Акції |
| PFA Pension, Forsikringsaktieselskab | $43 480 161 | 183 028 | 0,14% | Акції |
| Davidson Kempner Capital Management LP | $43 260 389 | 182 103 | 0,14% | Акції |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $42 795 484 | 180 146 | 0,14% | Акції |
| Pictet Asset Management Holding SA | $42 685 837 | 179 688 | 0,14% | Акції |
| OSAIC HOLDINGS, INC. | $41 443 725 | 174 339 | 0,13% | Акції |
| CHURCHILL MANAGEMENT Corp | $40 806 561 | 242 896 | 0,13% | Акції |
| JONES FINANCIAL COMPANIES LLLP | $40 701 876 | 171 074 | 0,13% | Акції |
| AMF Tjanstepension AB | $40 543 890 | 170 668 | 0,13% | Акції |
| Voleon Capital Management LP | $40 128 160 | 168 918 | 0,13% | Акції |
| CITADEL ADVISORS LLC | $40 028 860 | 168 500 | 0,13% | Опціон кол |
Інсайдери компанії 85 інсайдерів · 45 керівники · 37 директори
| Інсайдер | Роль | Остання активність | Кількість акцій у власності | Купівлі за 12 міс. | Продажі за 12 міс. | Нетто 12 міс |
|---|---|---|---|---|---|---|
| Deborah Weitzman | CEO, PSS Segment | 15 серпня 2026 р. F | 85 255 | 0 | 1 | $-3 216 375 |
| Stephen M Mason | CEO, GMPD Segment | 15 серпня 2026 р. F | 53 061 | 0 | 3 | $-6 187 063 |
| Jason M. Hollar | Chief Executive Officer | 15 серпня 2026 р. F | 315 132 | 0 | 5 | $-21 424 216 |
| Michael C Kaufmann | CEO | 15 серпня 2022 р. M | 601 065 | 0 | 0 | $0 |
| Victor L. Crawford | CEO, Pharmaceutical Segment | 15 серпня 2022 р. F | 105 699 | 0 | 0 | $0 |
| Jon L Giacomin | CEO, Medical Segment | 15 серпня 2019 р. F | 61 387 | 0 | 0 | $0 |
| Donald M Casey Jr. | CEO, Medical Segment | 15 вересня 2017 р. F | 146 503 | 0 | 0 | $0 |
| Michael A Lynch | CEO, Medical Segment | 27 лютого 2012 р. M | 89 204 | 0 | 0 | $0 |
| Kerry R Clark | Former Chairman and CEO | 01 вересня 2009 р. A | 238 635 | 0 | 0 | $0 |
| Mark W Parrish | CEO - HSCS | 02 вересня 2007 р. F | 68 041 | 0 | 0 | $0 |
| Ronald K Labrum | CEO-Supply Chain Svcs. | 16 травня 2006 р. M | 36 082 | 0 | 0 | $0 |
| Joseph C Papa | Chmn & CEO, Pharm Techn & Svcs | 13 грудня 2004 р. A | 14 400 | 0 | 0 | $0 |
| Aaron E Alt | Chief Financial Officer | 15 серпня 2026 р. F | 62 495 | 0 | 2 | $-7 177 390 |
| Jorge M Gomez | Chief Financial Officer | 08 листопада 2018 р. F | 39 582 | 0 | 0 | $0 |
| Jeffrey William Henderson | Chief Financial Officer | 27 серпня 2014 р. M | 67 190 | 0 | 0 | $0 |
| Richard J Miller | EVP & CFO | 17 листопада 2003 р. A | — | 0 | 0 | $0 |
| George L Fotiades | President & COO | 15 січня 2003 р. P | 80 278 | 0 | 0 | $0 |
| Valerie Christine Pitteroff | Chief Human Resources Officer | 15 серпня 2026 р. F | 11 757 | 0 | 0 | $0 |
| Mary C. Scherer | Chief Accounting Officer | 15 серпня 2026 р. F | 5 113 | 0 | 1 | $-1 009 826 |
| Michelle D. Greene | Chief Information Officer | 15 серпня 2026 р. F | 21 980 | 0 | 2 | $-2 009 043 |
| Jessica L Mayer | Chief Legal/Compliance Officer | 15 серпня 2026 р. F | 62 512 | 0 | 3 | $-5 666 833 |
| Ola M Snow | Chief Human Resources Officer | 19 серпня 2025 р. S | 15 431 | 0 | 2 | $-4 192 917 |
| Patricia M English | Chief Accounting Officer | 15 серпня 2022 р. F | 9 000 | 0 | 0 | $0 |
| Brian S Rice | Chief Information Officer | 15 серпня 2022 р. F | 37 850 | 0 | 0 | $0 |
| Michele Holcomb | EVP - Strategy & Corp. Dev. | 15 серпня 2022 р. F | 44 491 | 0 | 0 | $0 |
| Stuart G Laws | SVP & Chief Accounting Officer | 15 серпня 2020 р. F | 12 289 | 0 | 0 | $0 |
| Craig S Morford | Chief Legal/Compliance Officer | 03 грудня 2018 р. F | 126 301 | 0 | 0 | $0 |
| Patricia Morrison | Chief Information Officer | 31 серпня 2018 р. F | 30 725 | 0 | 0 | $0 |
| Pamela O. Kimmet | Chief Human Resources Officer | 15 серпня 2018 р. F | 22 612 | 0 | 0 | $0 |
| George S Barrett | Executive Chairman | 15 серпня 2018 р. F | 502 630 | 0 | 0 | $0 |
| Carole S Watkins | Chief HR Officer | 20 травня 2016 р. M | 31 585 | 0 | 0 | $0 |
| Falk T Stephen | EVP, Gen. Counsel & Corp. Sec. | 30 листопада 2015 р. G | 32 455 | 0 | 0 | $0 |
| Meghan Fitzgerald | EVP, Strategy & Health Policy | 17 листопада 2015 р. F | 16 760 | 0 | 0 | $0 |
| Mark R Blake | EVP - Strategy & Corp. Dev. | 07 листопада 2014 р. M | 20 409 | 0 | 0 | $0 |
| Ivan K Fong | CLO & Secretary | 01 листопада 2008 р. F | 50 886 | 0 | 0 | $0 |
| Vivek Jain | EVP - Corp. Dev. & Strategy | 26 вересня 2008 р. A | 39 594 | 0 | 0 | $0 |
| Daniel J Walsh | EVP, Chf Ethcs & Compl Offcr | 26 листопада 2007 р. I | 1 740 | 0 | 0 | $0 |
| Eric Slusser | EVP, CAO & Controller | 04 червня 2007 р. M | 8 573 | 0 | 0 | $0 |
| Brendan A Ford | EVP-Corporate Development | 02 вересня 2006 р. F | 85 978 | 0 | 0 | $0 |
| RUCCI ANTHONY J | EVP & Chief Admin. Officer | 06 вересня 2005 р. G | 55 382 | 0 | 0 | $0 |
| Gary D Dolch | EVP - Quality & Reg. Affairs | 02 вересня 2005 р. A | 6 137 | 0 | 0 | $0 |
| Jody R Davids | EVP & CIO | 02 вересня 2005 р. A | 4 607 | 0 | 0 | $0 |
| Paul S Williams | EVP, CLO & Secretary | 17 лютого 2005 р. G | 7 000 | 0 | 0 | $0 |
| Gary S Jensen | SVP - Corporate Controller | 23 серпня 2004 р. A | 2 462 | 0 | 0 | $0 |
| Stephen S Thomas | EVP-Group Pres.-AIS | 24 лютого 2004 р. M | 31 039 | 0 | 0 | $0 |
| Hall Patricia Hemingway | Директор | 15 квітня 2026 р. A | 28 645 | 0 | 0 | $0 |
| Christine Mundkur | Директор | 05 листопада 2025 р. A | 7 536 | 0 | 0 | $0 |
| Gregory B Kenny | Директор | 05 листопада 2025 р. A | 64 194 | 0 | 0 | $0 |
| Sudhakar Ramakrishna | Директор | 15 березня 2025 р. A | 1 049 | 0 | 0 | $0 |
| Michelle Brennan | Директор | 06 листопада 2024 р. A | 7 019 | 0 | 0 | $0 |
Інсайдери згідно з формами SEC 3/4/5; чистий результат = лише відкритий ринок купівлі/продажу
Активісти та власники %+ 5 3 холдинги
Інвестори, які подали Розклад SEC 13D — бенефіціарна власність понад 5% з наміром вплинути на емітента (активістські частки, кампанії в раді директорів, M&A). Кожен рядок показує останній відомий стан позиції цього подавця.
| Подавець | Подано | Частка | Статус | Мета | Подача |
|---|---|---|---|---|---|
| Cardinal Health, Inc. ×2 подання | 05 червня 2014 р. | — | Первинна подача | — | SEC |
| Нерозкрита особа, що звітує | 02 липня 2004 р. | — | Первинна подача | — | SEC |
| Нерозкрита особа, що звітує | 28 травня 2004 р. | — | Первинна подача | M&A / продаж | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Присутність в ETF Належить 224 ETF
Вага відображає лише прямі акціонерні володіння (N-PORT); фонди з кредитним плечем або похідними інструментами можуть мати додаткову експозицію за свопами, яка не відображається.
| Фонд | Вага | Одиниці | Станом на | Джерело |
|---|---|---|---|---|
| EGGS · Tidal Trust III | 4,07% | 11 627 NS | 31 травня 2026 р. | N-PORT |
| BCUS · Exchange Listed Funds Trust | 2,96% | 16 250 NS | 31 травня 2026 р. | N-PORT |
| IYK · iShares Trust | 2,53% | 151 717 SH | 08 серпня 2026 р. | Щоденно |
| POWA · Invesco Exchange-Traded Self-Indexe… | 2,21% | 17 153 SH | 08 серпня 2026 р. | Щоденно |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,98% | 89 549 NS | 30 квітня 2026 р. | N-PORT |
| NUMV · Nushares ETF Trust | 1,83% | 40 961 NS | 30 квітня 2026 р. | N-PORT |
| FLOW · Global X Funds | 1,70% | 2 476 NS | 31 травня 2026 р. | N-PORT |
| ZECP · Zacks Trust | 1,69% | 29 490 NS | 31 травня 2026 р. | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,66% | 54 825 SH | 08 серпня 2026 р. | Щоденно |
| COWZ · Pacer Funds Trust | 1,62% | 1 528 597 NS | 30 квітня 2026 р. | N-PORT |
| QQWZ · Pacer Funds Trust | 1,62% | 3 926 NS | 30 квітня 2026 р. | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 1,56% | 118 283 SH | 08 серпня 2026 р. | Щоденно |
| NOBL · ProShares Trust | 1,41% | 791 661 NS | 31 травня 2026 р. | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1,38% | 796 NS | 30 квітня 2026 р. | N-PORT |
| KNG · First Trust Exchange-Traded Fund IV | 1,37% | 239 259 NS | 30 квітня 2026 р. | N-PORT |
| VFMV · VANGUARD WELLINGTON FUND | 1,34% | 23 570 SH | 08 серпня 2026 р. | Щоденно |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,34% | 563 995 SH | 08 серпня 2026 р. | Щоденно |
| GROZ · Zacks Trust | 1,19% | 5 456 NS | 31 травня 2026 р. | N-PORT |
| SRHQ · Elevation Series Trust | 1,09% | 10 932 NS | 30 квітня 2026 р. | N-PORT |
| SPVM · Invesco Exchange-Traded Fund Trust | 1,08% | 5 969 SH | 08 серпня 2026 р. | Щоденно |
| RPV · Invesco Exchange-Traded Fund Trust | 1,08% | 77 480 SH | 08 серпня 2026 р. | Щоденно |
| ESMV · iShares Trust | 1,06% | 350 SH | 08 серпня 2026 р. | Щоденно |
| NULV · Nushares ETF Trust | 1,03% | 110 401 NS | 30 квітня 2026 р. | N-PORT |
| AMOM · Exchange Listed Funds Trust | 1,00% | 1 584 NS | 30 квітня 2026 р. | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,96% | 1 504 470 SH | 08 серпня 2026 р. | Щоденно |
| VHT · VANGUARD WORLD FUND | 0,82% | 707 389 SH | 08 серпня 2026 р. | Щоденно |
| ABFL · Abacus FCF ETF Trust | 0,80% | 20 613 NS | 30 квітня 2026 р. | N-PORT |
| ROE · EA Series Trust | 0,79% | 10 387 NS | 29 травня 2026 р. | N-PORT |
| VAMO · Cambria ETF Trust | 0,78% | 3 359 NS | 30 квітня 2026 р. | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,74% | 387 NS | 31 травня 2026 р. | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,74% | 109 528 NS | 30 квітня 2026 р. | N-PORT |
| UPSD · ETF Series Solutions | 0,73% | 3 833 NS | 30 квітня 2026 р. | N-PORT |
| IWP · iShares Trust | 0,73% | 619 589 SH | 08 серпня 2026 р. | Щоденно |
| IXJ · iShares Trust | 0,70% | 122 846 SH | 08 серпня 2026 р. | Щоденно |
| LGDX · Tidal Trust III | 0,69% | 4 947 NS | 30 квітня 2026 р. | N-PORT |
| RXL · ProShares Trust | 0,67% | 2 454 NS | 31 травня 2026 р. | N-PORT |
| LSEQ · Harbor ETF Trust | 0,66% | 524 NS | 30 квітня 2026 р. | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,65% | 4 692 NS | 30 квітня 2026 р. | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,58% | 38 214 NS | 30 квітня 2026 р. | N-PORT |
| QARP · DBX ETF Trust | 0,58% | 2 209 NS | 29 травня 2026 р. | N-PORT |
| CLSE · Trust for Professional Managers | 0,58% | 18 083 NS | 31 травня 2026 р. | N-PORT |
| FLCV · Federated Hermes ETF Trust | 0,56% | 2 763 NS | 31 травня 2026 р. | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,54% | 5 075 476 SH | 08 серпня 2026 р. | Щоденно |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,52% | 4 667 NS | 30 квітня 2026 р. | N-PORT |
| ITAN · EA Series Trust | 0,50% | 2 246 NS | 29 травня 2026 р. | N-PORT |
| EVUS · iShares Trust | 0,49% | 7 746 SH | 08 серпня 2026 р. | Щоденно |
| KRMA · Global X Funds | 0,47% | 2 880 NS | 31 травня 2026 р. | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,47% | 18 983 SH | 08 серпня 2026 р. | Щоденно |
| JMID · Janus Detroit Street Trust | 0,45% | 423 NS | 30 квітня 2026 р. | N-PORT |
| SFGV · EA Series Trust | 0,42% | 24 321 NS | 29 травня 2026 р. | N-PORT |